Brad Lewis

Dr. Lewis is the Chief Medical Director of Machaon Diagnostics. Dr. Lewis is an expert in benign hematology with a focus on thrombosis and hemostasis. He regularly lectures around the U.S. and internationally on the clinical and laboratory approaches to diagnosing atypical Hemolytic Uremic Syndrome (aHUS) and Paroxysmal Nocturnal Hemoglobinuria (PNH). He is Professor Emeritus in Medicine/Hematology at University of California at San Francisco. He was the Regional Benign Hematology Expert for Kaiser Permanente Medical Group of Northern California. Dr. Lewis has provided clinical consultation on the majority of the thousands of suspected cases of aHUS sent to Machaon Diagnostics for complement and coagulation gene sequencing. He has developed a unique-to-Machaon expertise in the use of genetic sequencing data in the acute clinical setting when diagnosis has yet to be established.

Dr. Lewis holds a BS in History and biochemistry from MIT, an MA from Brandeis University and an MD from the UCLA School of Medicine. He completed his residency and Hematology fellowship at the University of Rochester.